Pfizer has completed settlement agreements with state attorneys regarding its NSAID pain medication Bextra [valdecoxib].

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1662, 2008-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pfizer's Bextra also associated with cardiovascular disorders?

By  

Reactions Weekly, Vol. 1, Iss. 1028, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Valdecoxib effective against postoperative pain

By  

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Valdecoxib: A Review of its Use in the Management of Osteoarthritis, Rheumatoid Arthritis, Dysmenorrhoea and Acute Pain

By Fenton C.   Keating G.M.   Wagstaff A.J.  

Drugs, Vol. 64, Iss. 11, 2004-01 ,pp. : 1231-1261

Adis International

Access to resources Recommend Favorite

Alexza Pharmaceuticals has announced that it has completed enrolment in its second phase III trial with loxapine

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Merck Sharpe and Dohme has launched new formulations for all dosage strengths of its NSAID etoricoxib [Arcoxia]

By  

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite